Insulet received 510(k) clearance for Omnipod Dash in June 2018. This past September, FDA authorized the technology as an alternate controller enabled, or ACE, pump, setting it up for use in Insulet's forthcoming Horizon automated insulin delivery system. That system will be compatible with Dexcom continuous glucose monitors. Insulet has said it hopes to launch Horizon in the second half of 2020. It may offer status updates on its earnings call scheduled for Feb. 25.